Press release
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric Population In The Anti-Parkinson Drugs Market
Anti-Parkinson Drugs Market
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced healthcare infrastructure, and progress in research.
The market for anti-Parkinson's medication is projected to experience significant expansion in the coming years. By 2029, it is set to rise to a value of $13.73 billion with a 5.5% compound annual growth rate (CAGR). Factors contributing to growth throughout the prediction period include increased awareness, biotechnological progression, and emerging markets. Crucial trends expected in the prediction timeframe consist of r&d investments, personalized healthcare, disease-altering treatments, drug rediscovery, telemedicine & remote patient monitoring, biosimilars, and research partnerships.
What Are the Main Catalysts for Growth in the Anti-Parkinson Drugs Market?
The surge in the aging population and the escalating number of Parkinson's disease cases (PD) are anticipated to propel the anti-Parkinson drugs market's demand. PD is prevalent in individuals over 60 years. As per the World Health Organization's reports in October 2022, a health organization based in the US estimated that by 2030, 1 in every six individuals worldwide will be 60 or above, and by 2050, the number of people in this age group will double to 2.1 billion. Consequently, the accelerating geriatric population is driving the expansion of the anti-Parkinson drugs market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3462&type=smp
Which Businesses Are at the Forefront of Anti-Parkinson Drugs Market Development?
Major companies operating in the anti-parkinson drugs market include GlaxoSmithKline plc, Pfizer Inc., Merck Co., Novartis AG, F. Hoffmann-La Roche AG, UCB S.A, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Mylan NV, C.H. Boehringer Sohn AG & Co. KG, Orion Pharma Ltd., ACADIA Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., Reddy's Laboratories Ltd., Intas Pharmaceuticals Ltd., US WorldMeds LLC, Zydus Lifesciences Limited, Chemical Industrial & Pharmaceutical Laboratories Ltd., Strides Shasun Ltd., Axcan Pharma Inc., Upsher-Smith Laboratories LLC, H. Lundbeck A/S, Vertical Pharmaceuticals LLC, Zambon SPA, M Somerset Pharmaceuticals Inc., Valeant Pharmaceuticals International Inc., Neurocrine Biosciences Inc., Supernus Pharmaceuticals Inc.
What Are the Latest Innovations in the Anti-Parkinson Drugs Market?
Leading businesses in the anti-Parkinson drugs market are concentrating their efforts on creating sophisticated therapeutic answers like motor fluctuations and dyskinesia to improve symptom regulation while reducing side effects. These issues often complicate Parkinson's disease treatment, negatively impacting patient welfare. For example, AbbVie Inc., a pharmaceutical firm based in the United States, introduced PRODUODOPA in January 2024. PRODUODOPA, which consists of foslevodopa/foscarbidopa, is a pioneering 24-hour subcutaneous infusion therapy for advanced Parkinson's disease that specifically treats severe motor fluctuations and dyskinesia when other treatments are ineffective. It delivers levodopa continuously, potentially enhancing the 'on' time and bettering symptom management.
How Is the Anti-Parkinson Drugs Market Segmented?
The anti-parkinson drugs market covered in this report is segmented -
1) By Drugs Class: Levodopa Or Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, Anticholinergics, Other Drugs
2) By Route of Administration: Oral, Injection, Transdermal
3) By Distribution Channel: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies
Subsegments:
1) By Levodopa Or Carbidopa: Immediate-Release Levodopa Or Carbidopa, Extended-Release Levodopa Or Carbidopa
2) By Dopamine Receptor Agonists: Pramipexole, Ropinirole, Rotigotine
3) By Monoamine Oxidase Type B (MAO-B) Inhibitors: Selegiline, Rasagiline, Safinamide
4) By Catechol-O-Methyltransferase (COMT)-Inhibitors: Entacapone, Tolcapone
5) By Anticholinergics: Benztropine, Trihexyphenidyl
6) By Other Drugs: Amantadine, Apomorphine
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/anti-parkinson-drugs-global-market-report
Where Is the Anti-Parkinson Drugs Market Growth Most Prominent?
North America was the largest region in the anti-Parkinson drugs market in 2023. Middle East is expected to be the fastest-growing region in the anti-parkinson drugs market during the forecast period. The regions covered in the anti-parkinson drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Is Covered In The Anti-Parkinson Drugs Global Market Report?
- Market Size Analysis: Analyze the Anti-Parkinson Drugs Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Anti-Parkinson Drugs Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Anti-Parkinson Drugs Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Anti-Parkinson Drugs Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3462
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric Population In The Anti-Parkinson Drugs Market here
News-ID: 3872030 • Views: …
More Releases from The Business Research Company
Technological Advancements With App Based Subscription Programs Industry Trends …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Car Washing Service Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent years, the car washing service market size has been expanding at a consistent rate. It is projected that from $30.1 billion in 2024, it will surge to $30.75 billion in 2025, with…
Major Growth Driver Identified in 2025 Well Intervention Market: Rising Energy D …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Well Intervention Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The size of the well intervention market has seen consistent growth over the past few years. The market, which will increase from $9.39 billion in 2024 to $9.84 billion in 2025 at a compound annual…
Growing E-Commerce Sector Fuels Demand For Telephone Call Centers: Critical Driv …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Telephone Call Centers Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for telephone call centers has seen a slight rise in recent years. The market value is predicted to increase from $136.61 billion in 2024 to $138.62 billion in 2025, maintaining a compound…
Private Household Services Market Expansion Continues, with Forecast Valuation o …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Private Household Services Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
There has been a significant expansion in the private household services market size in the past few years. This market will see an escalation from $321.58 billion in 2024 to $351.99 billion in 2025,…
More Releases for Parkinson
Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025?
The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.…
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period?
The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.43 billion…
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%.
Increasing Geriatric Population Driving Demand:
The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,…
QualitySolicitors Parkinson Wright invest in the future
QualitySolicitors Parkinson Wright has selected Liberate from Linetime as its business-wide legal services software platform. The Worcestershire based practice, with over 100 staff, operate from 4 offices and have a highly regarded reputation for their services including residential property, private client, family, dispute resolution and commercial. The firm also has its own estate agency.
The firm recognised that to continue delivering high quality services to its clients it needed to provide…
